在针对性药物问世前，治疗手段十分有限且充满挑战。外科肢体延长术创伤性强、风险高，且行业内尚未形成统一诊疗共识；重组人生长激素（rhGH）虽能在一定程度上改善生长状况，但疗效有限，治疗2年后骨骼生长的有益作用便会减弱，还存在显著的长期副作用。
Creator: $24/month
。同城约会对此有专业解读
Why the FT?See why over a million readers pay to read the Financial Times.
55. 2026 Education Degree Programs for Career Changers - Research.com, research.com/advice/educ…